Geron used to be called "the baby killer company" by the religious right for their work in human embryonic stem cells. I was convinced back then that it was being targeted by a coalition of institutions and individuals of that mind set, although I was was told that would be difficult to do (not impossible, just difficult). So, IF they were being targeted back then, have things changed all that much? Don't have answers, only suspicions. I've always believed however, that once they are proven to have the goods, any attempt to hold the company down would be futile, and costly. So the second question is: Have we passed the threshold of proof yet? Perhaps not. But it would appear that it's only a matter of time, and little time, at that.
Don't know about "shorts getting nervous," but it does suggest that there are buyers waiting in the wings looking for any sign that the price has bottomed, and is on its way back up. I suspect there are quite a few of them, in fact.
No doubt there are chartists among you with far more knowledge than mine, but as I look at the basic chart I have the warm felling that everything is just fine. That might change, of course, but I see absolutely no reason for all the hand wringing that has gone on here. Look at it for yourself; looks like a normal correction to me. If I'm right, we should soon start another leg up.
Thanks for your continuing research and responsible posting.
Or, he can't say because he would be unduly influencing the stock price. Er, isn't that illegal?
Someday, after we've been approved by the FDA, Imetelstat will be used in treating early stage cancers, rather than the very advanced forms subject to trial. Then its true potential might be realized. But I also believe that before approval, based on the Mayo results, other researchers might begin to explore its effectiveness in treating other cancers. The journey has just begun, JMO
I think we were being set up to be "milked" like the last time (i.e. following the CEO's presentation). Remember the huge spike and then the profit taking, all so fast it made your head spin. Didn't happen this time, so the traders are all backing out. Hope they lost $, lot's of it. More serious money will begin to look at Geron now.
As typical in these situations, there has been entirely too much of it all on this board, and yet it continues. It's hard to be heard in all this wind, but for those of us who have been here a long time, this is just a step toward a big payoff, which IMO will begin to come together not far down the road. If there's a stock that ever had a straight rise to top, I've never found it, especially one in the biotech sector. Give it some room, and time. With the results now reported, things are going to change dramatically I predict. Other cancer researchers are going to take a very serious look at Imetelstat, and we might find that it's potential and utility in cancer therapy is only beginning to be unlocked. I believe we have a winner, but proving it is another matter.
I believe the Imetelstat story is just beginning and that it will be very successful, possibly beyond our greatest imaginings. But it will take time, as you say. I think there will be a "short story" and a "long story." The short one needs to unfold soon for us to stay alive. The longer one can take its sweet time.
The real questions are: What lies ahead, how do we get there, and how much time will it take? In the end, follow the money!
A "cure for cancer" is quite a broad statement. That it is not! Certainly not at this time, anyway, and personally, I think never. But I do think the story of interfering with the activity of telomerase in cancer cells is just beginning to unfold. It has a long way to go. JMO
I still expect good news. However, it will be up to the FDA to give us the news we really need, IMO. Totally agree about the excess optimism, which I have cautioned against for a long time now. But I still don't think that it (the optimism) has been excessively prices in at t his time. Again, we shall see. I would be most pleased to see lift off tomorrow, been waiting a long time.
and will again, "When news comes that really propels this stock upward, it will be a surprise (i.e. not known at a specific time and place in advance.) That is, of course, unless something is said that was totally unanticipated. Otherwise, it's been priced in already. We shall see.